Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. L-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1h-4-benzazonine Hydrobromide
2. L-st-2121
3. St 2121
4. St-2121
1. Sedapain (tn)
2. Eptazocine Hbr
3. Eptazocine Hydrobromide [jan]
4. L-st-2121
5. St-2121
6. Unii-865626y4on
7. St 2121, L-
8. Mcv 4169
9. 865626y4on
10. Eptazocine Hydrobromide (jan)
11. Mcv-4169
12. Sedapain
13. Eptazocine Hydrobromide [mart.]
14. Eptazocine Hydrobromide [who-dd]
15. (-)-nih-9614
16. (-)-st-2121
17. (-)-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1h-4-benzazonine Hydrobromide
18. (-)-2,3,4,5,6,7-hexahydro-1,4-dimethyl-1,6-methano-1h-4-benzazonin-10-ol Hydrobromide
19. L-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1h-4-benzazonine Hydrobromide
20. Eptazocine Hydrobromide (mart.)
21. (-)-(1s,6s)-2,3,4,5,6,7-hexahydro-1,4-dimethyl-1,6-methano-1h-4-benzazonin-10-ol Hbr
22. (-)-(1s,6s)-2,3,4,5,6,7-hexahydro-1,4-dimethyl-1,6-methano-1h-4-benzazonin-10-ol Hydrobromide
23. 1,6-methano-1h-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, Hbr (1:1), (1s,6s)-
24. 1,6-methano-1h-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, Hydrobromide (1:1), (1s,6s)-
25. 1,6-methano-1h-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, Hydrobromide, (-)-
26. (-)-nih 9614
27. 1,6-methano-1h-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, Hydrobromide, (1s)-
28. 72150-17-5
29. (1s,9s)-1,11-dimethyl-11-azatricyclo[7.4.1.02,7]tetradeca-2(7),3,5-trien-4-ol;hydrobromide
30. 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1h-4-benzazonine Hydrobromide
31. Sedapain (hydrobromide)
32. 1,6-methano-1h-4-benzazonin-10-ol,2,3,4,5,6,7-hexahydro-1,4-dimethyl-, Hydrobromide, (1s,6s)-
33. Eptazocine (hydrobromide)
34. Schembl395495
35. Chebi:31553
36. D01879
37. Q27269706
Molecular Weight | 312.24 g/mol |
---|---|
Molecular Formula | C15H22BrNO |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 23.5 |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 293 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
29
PharmaCompass offers a list of Eptazocine Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eptazocine Hydrobromide manufacturer or Eptazocine Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eptazocine Hydrobromide manufacturer or Eptazocine Hydrobromide supplier.
PharmaCompass also assists you with knowing the Eptazocine Hydrobromide API Price utilized in the formulation of products. Eptazocine Hydrobromide API Price is not always fixed or binding as the Eptazocine Hydrobromide Price is obtained through a variety of data sources. The Eptazocine Hydrobromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Eptazocine Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eptazocine Hydrobromide, including repackagers and relabelers. The FDA regulates Eptazocine Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eptazocine Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eptazocine Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eptazocine Hydrobromide supplier is an individual or a company that provides Eptazocine Hydrobromide active pharmaceutical ingredient (API) or Eptazocine Hydrobromide finished formulations upon request. The Eptazocine Hydrobromide suppliers may include Eptazocine Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Eptazocine Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Eptazocine Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eptazocine Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eptazocine Hydrobromide GMP manufacturer or Eptazocine Hydrobromide GMP API supplier for your needs.
A Eptazocine Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Eptazocine Hydrobromide's compliance with Eptazocine Hydrobromide specifications and serves as a tool for batch-level quality control.
Eptazocine Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Eptazocine Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eptazocine Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Eptazocine Hydrobromide EP), Eptazocine Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eptazocine Hydrobromide USP).